Berkeley Lights IPO Presentation Deck
Growing workflow offering with a high degree of R&D leverage
High degree of
leverage across
markets, applications
and customers
Workflows in development
Opto Viral Neutralization 1.0
Opto Cell Therapy Development 2.0
Opto Cell Therapy Manufacturing
Opto Cell Therapy Patient Monitoring
Opto SynBio Discovery 1.0
Opto SynBio Development 1.0
IGT
Antibody therapeutics
Cell therapy
Synthetic biology
6
2015
2016
As of April 30, 2020
2 Planned
2018
6 commercial
workflows¹
Opto Cell Therapy Development 1.0
Opto Plasma B Discovery 3.0
Opto Cell Line Development 2.0
Opto Cell Line Development 1.0
2017
2019
2020
Opto Plasma B Discovery 2.0
Opto Plasma B Discovery 1.0
Developing a new
workflow is a function
of adding new single
cell assays, changing
one or more of the four
modules or cell types
Our 6 commercial workflows, incorporate 16
assays and over 11 cell classes
22View entire presentation